Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS

Tohoku J Exp Med. 1980 Jan;130(1):49-53. doi: 10.1620/tjem.130.49.

Abstract

Experimental immunotherapy with a mixture of allogeneic tumor cells and BCG cell-wall skeleton (BCG-CWS) was carried out against established autochthonous fibrosarcomas induced by 3-methylcholanthrene (MCA) in the subcutaneous tissue of rats. The inhibitory effect on growth in the early stage, tumor-size up to 2 cm in diameter, was significantly observed. No significant difference, however, was shown as compared with the effect of treatment with allogeneic tumor cells alone. That is to say, a more effective inhibition of growth due to the addition of BCG-CWS was not demonstrated.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • BCG Vaccine / therapeutic use*
  • Cell Wall / immunology
  • Fibrosarcoma / therapy
  • Immunization
  • Immunotherapy / methods*
  • Male
  • Methylcholanthrene
  • Neoplasm Transplantation*
  • Rats
  • Sarcoma, Experimental / chemically induced
  • Sarcoma, Experimental / therapy*
  • Time Factors
  • Transplantation, Homologous

Substances

  • BCG Vaccine
  • Methylcholanthrene